These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9176720

  • 1. Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Serranò M, Minutoli L, Arlotta M, Musolino C, Saitta A, Caputi AP.
    Int J Microcirc Clin Exp; 1997; 17(1):10-4. PubMed ID: 9176720
    [Abstract] [Full Text] [Related]

  • 2. The effects of recombinant human granulocyte-colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP.
    Br J Pharmacol; 1997 Jan; 120(2):333-9. PubMed ID: 9117128
    [Abstract] [Full Text] [Related]

  • 3. Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Canale P, Rossi F, Saitta A, Caputi AP.
    Br J Pharmacol; 1996 Sep; 119(1):23-8. PubMed ID: 8872352
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP.
    Br J Pharmacol; 1999 May; 127(2):482-8. PubMed ID: 10385249
    [Abstract] [Full Text] [Related]

  • 5. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Canale P, Ioculano M, Campo GM, Ammendolia L, Ferlito M, Zingarelli B, Squadrito G, Saitta A.
    Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Deodato B, Arlotta M, Minutoli L, Campo GM, Bova A, Quartarone C, Urna G, Sardella A, Saitta A, Caputi AP.
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [Abstract] [Full Text] [Related]

  • 7. The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
    Altavilla D, Squadrito F, Campo GM, Squadrito G, Arlotta M, Urna G, Sardella A, Quartarone C, Saitta A, Caputi AP.
    Eur J Pharmacol; 1999 Mar 12; 369(1):49-55. PubMed ID: 10204681
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Ferlito M, Campo GM, Arlotta M, Grimaldi S, Quartarone C, Saitta A, Caputi AP.
    Br J Pharmacol; 1999 May 12; 127(2):498-504. PubMed ID: 10385251
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ.
    Br J Pharmacol; 1996 Aug 12; 118(7):1659-68. PubMed ID: 8842429
    [Abstract] [Full Text] [Related]

  • 10. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Minutoli L, Ferlito M, Saitta A, Caputi AP.
    Eur J Pharmacol; 1998 Nov 13; 361(1):101-8. PubMed ID: 9851547
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA, Narayanan K, Griffith OW, Kilbourn RG.
    Br J Pharmacol; 1995 Jun 13; 115(3):491-7. PubMed ID: 7582462
    [Abstract] [Full Text] [Related]

  • 12. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
    Scott JA, Machoun M, McCormack DG.
    J Appl Physiol (1985); 1996 Jan 13; 80(1):271-7. PubMed ID: 8847314
    [Abstract] [Full Text] [Related]

  • 13. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
    Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA.
    Eur J Pharmacol; 1997 Jun 25; 329(2-3):137-46. PubMed ID: 9226406
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of inducible nitric oxide synthase gene expression and nitric oxide synthesis in vascular smooth muscle cells by granulocyte-colony stimulating factor in vitro.
    Deetjen C, Frede S, Smolny M, Seibel M, Schobersberger W, Hoffmann G.
    Immunopharmacology; 1999 Jun 25; 43(1):23-30. PubMed ID: 10437653
    [Abstract] [Full Text] [Related]

  • 15. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
    McKendrick JD, Paisley K, Eason S, Mian KB, Martin W.
    Arch Int Pharmacodyn Ther; 1995 Jun 25; 330(2):206-24. PubMed ID: 8861713
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia.
    Wu CC, Liao MH, Chen SJ, Yen MH.
    Eur J Pharmacol; 1999 May 28; 373(1):41-9. PubMed ID: 10408250
    [Abstract] [Full Text] [Related]

  • 18. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
    Thiemermann C, Szabó C, Mitchell JA, Vane JR.
    Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):267-71. PubMed ID: 7678341
    [Abstract] [Full Text] [Related]

  • 19. Effect of halothane on phenylephrine-induced vascular smooth muscle contractions in endotoxin-exposed rat aortic rings.
    Grissom TE, Bina S, Hart J, Muldoon SM.
    Crit Care Med; 1996 Feb 01; 24(2):287-93. PubMed ID: 8605803
    [Abstract] [Full Text] [Related]

  • 20. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.
    Kim ND, Kim EM, Kang KW, Cho MK, Choi SY, Kim SG.
    Br J Pharmacol; 2003 Oct 01; 140(4):661-70. PubMed ID: 14534150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.